These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 21418126)

  • 1. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
    Kindt S; Imschoot J; Tack J
    Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.
    Kahrilas PJ; Howden CW; Wernersson B; Denison H; Nuevo J; Gisbert JP
    Aliment Pharmacol Ther; 2013 May; 37(10):1005-10. PubMed ID: 23557078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
    Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
    Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M; Miwa H; Kusano M;
    J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway symptoms and sleeping difficulties in operated and non-operated patients with gastroesophageal reflux disease.
    Johannessen R; Petersen H; Olberg P; Johnsen G; Fjøsne U; Kleveland PM
    Scand J Gastroenterol; 2012 Jul; 47(7):762-9. PubMed ID: 22571295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
    Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
    Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
    Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
    Johnson D; Crawley JA; Hwang C; Brown K
    Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for nocturnal reflux in a large GERD cohort.
    Gaddam S; Maddur H; Wani S; Gupta N; Singh M; Singh V; Moloney B; Puli SR; Rastogi A; Bansal A; Sharma P
    J Clin Gastroenterol; 2011 Oct; 45(9):764-8. PubMed ID: 21633310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical characteristics of gastroesophageal reflux disease in patients with laryngeal symptoms who are referred to gastroenterology.
    Oh JH; Choi MG; Park JM; Lim CH; Cho YK; Lee IS; Kim SW; Chung IS
    Dis Esophagus; 2013 Jul; 26(5):465-9. PubMed ID: 22816650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and psychosocial impact of different reflux time in gastroesophageal reflux disease patients.
    Chen JH; Wen SH; Hsu CS; Yi CH; Liu TT; Chen CL; Wang CC
    J Formos Med Assoc; 2017 Feb; 116(2):123-128. PubMed ID: 27133182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
    Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
    Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
    Johnson DA; Katz PO
    Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of proton pump inhibitors in the treatment of patients with endoscopic esophagitis.
    Gashi Z; Haziri A; Berisha D; Zekaj S; Polloshka A; Bakalli A; Juniku A; Sadriu L
    Med Arh; 2010; 64(6):362-4. PubMed ID: 21218756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association.
    Shaker R; Castell DO; Schoenfeld PS; Spechler SJ
    Am J Gastroenterol; 2003 Jul; 98(7):1487-93. PubMed ID: 12873567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.